by Alex Berenson, Unreported Truths:
Gottlieb – Pfizer director, Biden v Berenson defendant – is openly trying to block RFK from the Dept. of Health and Human Services. His pharma paymasters must be even more worried than I thought.
If I’ve learned anything about Dr. Scott Gottlieb while suing him for his role in making Twitter censor me in 2021, it’s that he thrives in darkness.
TRUTH LIVES on at https://sgtreport.tv/
Which is why his open attack on Robert F. Kennedy Jr. shows how badly Big Pharma wants to keep Kennedy from the federal government’s top healthcare job – Secretary of Health and Human Services.
Gottlieb is a walking, talking conflict of interest who personifies everything wrong with American medicine. In May 2017, he became Food and Drug Administration commissioner. Less than two years later, he quit. Barely three months later, he joined the board of Pfizer, which has paid him about $2 million since then.
It’s not just Pfizer. Gottlieb has worked as an advisor, director, or investor at dozens of other healthcare companies. He regularly appears on CNBC and CBS too, offering independent opinions – independent opinions that almost always benefit Pfizer and his other paymasters. When he last practiced medicine is unclear, though a resume from 2015 suggests he last worked as a hospital internist in 2012.
But Gottlieb’s seamiest turn through the revolving door came earlier, and involved fentanyl, the opioid that has killed almost 1 million Americans.
In 2006, during his first FDA stint, Gottlieb “tried to help a pharmaceutical company secure more fentanyl,” in the words of the Washington Post. The drugmaker, Cephalon, was pushing its Actiq fentanyl lollipops for widespread “off-label” use, though the FDA had approved them only for patients with late-stage cancer.
Gottlieb left the FDA in 2007 – and went on to write a report defending Cephalon in a Pennsylvania lawsuit over Actiq. The judge in the case referred to him as “Cephalon’s regulatory expert” in a March 2015 ruling.
Yet Gottlieb never disclosed receiving payments from Cephalon during his 2017 Senate confirmation hearings to become FDA commissioner, apparently because the law firm that Cephalon hired paid him, not the company itself.
—
(Also, in the opinion of Cephalon’s regulatory expert, fentanyl lollies are super-tasty! Especially the grape!1)
—
Now Robert F. Kennedy Jr. is about to face his own Senate confirmation hearings, to become Donald Trump’s Secretary of Health and Human Services.
Gottlieb is trying to stop him. Last week, he went on CNBC to claim that Kennedy would “cost lives” in his new job.
As Unreported Truths readers know, I disagree with some of Kennedy’s views, which can be overly conspiratorial.
But I agree with his core premise that the $5-trillion-a-year United States biomedical complex – including everything from basic research to drug development to hospitals to insurers – is out-of-control, too often hurts patients, and costs far more than it should.
Read More @ alexberenson.substack.com
